ScienceDirect ® is a registered trademark of Elsevier B.V. ScienceDirect ® is a registered trademark of Elsevier B.V. Submit your article. View aims and scope. Molecular Therapy Impact Factors Jump Nearly 28 Percent Across Family of Titles. RSS. Find out more. https://doi.org/10.1016/j.ymthe.2020.11.009, https://doi.org/10.1016/j.ymthe.2020.11.025, https://doi.org/10.1016/j.ymthe.2020.11.026, Francesca Tucci, ... Alessandra Mortellaro, https://doi.org/10.1016/j.ymthe.2020.11.020, https://doi.org/10.1016/j.ymthe.2020.11.022, https://doi.org/10.1016/j.ymthe.2020.11.023, https://doi.org/10.1016/j.ymthe.2020.11.024, https://doi.org/10.1016/j.ymthe.2020.11.021, American Society for Gene and Cell Therapy, Single-Base Resolution: Increasing the Specificity of the CRISPR-Cas System in Gene Editing, Evaluating the genomic parameters governing rAAV-mediated homologous recombination, Targeted in vivo delivery of NF-κB decoy inhibitor augments sensitivity of B-cell lymphoma to therapy, Update on clinical ex vivo hematopoietic stem cell gene therapy for inherited monogenic diseases, The miR-5694/AF9/Snail axis provides metastatic advantages and a therapeutic target in basal-like breast cancer, CRISPR/Cas9-mediated gene correction in newborn rabbits with hereditary tyrosinemia type I. M2 macrophage-derived exosomes promote angiogenesis and growth of pancreatic ductal adenocarcinoma by targeting E2F2. Impact Factor: 6.448 ℹ Impact Factor: 2019: 6.448 The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. PDE10A inhibition reduces the manifestation of pathology in DMD zebrafish and represses the genetic modifier PITPNA, 23rd Annual Meeting of the American Society for Gene and Cell Therapy - Complete list of abstracts for the 23rd Annual Meeting of the American Society for Gene and Cell Therapy to be held virtually on May 12-15, 2020, ASGCT 22nd Annual Meeting - Complete listing of accepted abstracts for presentation at ASGCT's 22nd Annual Meeting in Washington, DC, April 29-May 2, 2019 - 22nd Annual Meeting of the American Society of Gene and Cell Therapy, ASGCT 21st Annual Meeting - Complete listing of accepted abstracts - 21st Annual Meeting of the American Society of Gene and Cell Therapy, ASGCT Annual Meeting - Complete listing of accepted abstracts for presentation at ASGCT's 20th Annual Meeting in Washington, DC, May 10-13, 2017. Copyright © 2020 Elsevier B.V. or its licensors or contributors. Annual Meeting Call for Abstracts Opens November 16. Published by Elsevier Inc. We use cookies to help provide and enhance our service and tailor content and ads. Latest issues. RSS | open access RSS. 2303–2518 (4 November 2020) Volume 28, Issue 10. pp. By continuing you agree to the use of cookies. ASGCT Staff - June 26, 2019. Explore journal content Latest issue Articles in press Article collections All issues. Looking for an author or a specific volume/issue? Sign in to set up alerts. https://doi.org/10.1016/j.omtn.2020.11.017, https://doi.org/10.1016/j.omtn.2020.11.016, https://doi.org/10.1016/j.omtn.2020.11.015, https://doi.org/10.1016/j.omtn.2020.11.013, https://doi.org/10.1016/j.omtn.2020.11.018, https://doi.org/10.1016/j.omtn.2020.11.019, https://doi.org/10.1016/j.omtn.2020.11.014, https://doi.org/10.1016/j.omtn.2020.11.020, The miR-93-3p/ZFP36L1/ZFX axis regulates keratinocyte proliferation and migration during skin wound healing, Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide, SIRT1 Alleviates Hepatic Ischemia-Reperfusion Injury Via the miR-182-Mediated XBP1/NLRP3 Pathway, Transfer of microRNA-25 by colorectal cancer cell-derived extracellular vesicles facilitates colorectal cancer development and metastasis, Oncogenic miR-27a delivered by exosomes binds to SFRP1 and promotes angiogenesis in renal clear cell carcinoma, Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy, International Conference on Aptamers in Russia - 1st International Conference on Aptamers in Russia, Molecular Therapy - Methods & Clinical Development. 17 to 28; 2009 to 2020; Vol. Volume 22. All rights reserved. Copyright © 2020 The American Society of Gene and Cell Therapy. Journal Citation Reports (Clarivate Analytics, 2020) 5-Year Impact Factor: 7.118 ℹ Five-Year Impact Factor: 2019: 7.118 You Can Still Register for On-Demand Access. Sign in to set up alerts. 7.032 Impact Factor. Molecular Therapy Vols. 1933–2096 (2 September 2020) Volume 28, Issue 8. pp. ScienceDirect ® is a registered trademark of Elsevier B.V. ScienceDirect ® is a registered trademark of Elsevier B.V. By continuing you agree to the use of cookies. Looking for an author or a specific volume/issue? The Journal Impact 2019-2020 of Molecular Therapy is 7.470, which is just updated in 2020. In progress (4 December 2020) Volume 21. pp. Compared with historical Journal Impact data, the Metric 2019 of Molecular Therapy - Methods and Clinical Development grew by 17.04% . Compared with historical Journal Impact data, the Metric 2019 of Molecular Therapy grew by 3.61%. 8.986 Impact Factor. The Journal Impact 2019-2020 of Molecular Therapy - Methods and Clinical Development is 3.640, which is just updated in 2020. 2097–2302 (7 October 2020) Volume 28, Issue 9. pp. 1–894 (5 June 2020) Volume 19. pp. Explore journal content Latest issue Articles in press Article collections All issues. - 20th Annual Meeting of the American Society of Gene and Cell Therapy, Molecular Therapy - Methods & Clinical Development. Latest issues. All presentations from the 2020 Policy Summit are available for registered attendees to view through October 25. Submit your paper on imaging and gene therapy to a special issue of Molecular Therapy Oncolytics. 1–1482 (6 March 2020) View all issues. Parent journal, Molecular Therapy, now tops the field with a 19.9 percent jump in impact factor to 8.402. Volume 28, Issue 11. pp. The Journal Impact Quartile of Molecular Therapy is Q1. 28 2020: v.28(1): 1–340 2020 Jan 8: v.28(2): 341–689 2020 Feb 5: v.28(3): 691–985 2020 Mar 4: v.28(4): 987–1228 2020 Apr 8: v.28(5): 1229–1380 2020 May 6: v.28(6): 1381–1546 2020 Jun 3: v.28(7): 1547–1740 2020 Jul 8: v.28(8): 1741–1932 2020 Aug 5: v.28(9): 1933–2095 2020 Sep 2: v.28(10): 2097–2301 2020 Oct 7: Vol. Molecular Therapy Impact Factor, IF, number of article, detailed information and journal … View aims and scope. We use cookies to help provide and enhance our service and tailor content and ads. Copyright © 2020 The American Society of Gene and Cell Therapy. 1–1122 (4 September 2020) Volume 20. pp. Copyright © 2020 Elsevier B.V. or its licensors or contributors.